This article is second in the series that enlists reviewed updates in Obstetrics and Gynecology, 2016. OFFICE GYNECOLOGY No role for routine serologic screening for genital herpes infection Transmission can occur even in the absence of symptoms. Due to the low specificity and high false positive rate of serologic tests for HSV-2 and the inability of serologic tests for HSV-1 to differentiate oral from genital infection.
No specific treatment interventions for asymptomatic patients exists, so the anxiety and disruption of personal relationships associated with a positive test outweigh any potential benefits. Vaginal prasterone for dyspareunia in postmenopausal women In November 2016, the US FDA approved the use of prasterone (also known as dehydroepiandrosterone [DHEA]) for the treatment of dyspareunia in women with vulvovaginal atrophy (VVA) due to menopause. In the case of moderate to…
